Alla S A, Buschko J, Quitterer U, Maidhof A, Haasemann M, Breipohl G, Knolle J, Müller-Esterl W
Institute for Physiological Chemistry and Pathobiochemistry, University of Mainz, Germany.
J Biol Chem. 1993 Aug 15;268(23):17277-85.
The human bradykinin B2 receptor belongs to the family of G-protein-coupled receptors. To characterize the receptor protein, we have solubilized the membranes of cultured human foreskin fibroblasts bearing the B2 receptor. Affinity cross-linking of the solubilized receptor with the labeled agonist, 125I-Tyr0-bradykinin, or the labeled antagonist, 125I-(4-hydroxy-phenyl-propionyl)-HOE140, revealed major bands of apparent molecular mass of 69 kDa in SDS-polyacrylamide gel electrophoresis under reducing conditions, and of 59 kDa under non-reducing conditions. A 1000-fold molar excess of each of the unlabeled ligands quenched the specific labeling suggesting that the agonist and the antagonist compete for overlapping binding site(s). Covalent coupling of the receptor to bradykinin or HOE140, followed by Western blotting and immunoprinting with specific anti-ligand antibodies confirmed that the major ligand-binding form of the receptor is of 69 kDa. Anti-idiotypic antibodies which bear the internal image of bradykinin (Haasemann, M., Buschko, J., Faussner, A., Roscher, A.A., Hoebeke, J., Burch, R.M., and Müller-Esterl, W. (1991) J. Immunol. 147, 3882-3892) immunoprecipitated the 125I-labeled receptor as a major band of 68 kDa and a minor band of 47 kDa indicative of partial proteolysis. Chemical deglycosylation of the 125I-labeled receptor shifted the apparent molecular mass from 69 to 44 kDa demonstrating that the receptor is heavily glycosylated. Two-dimensional electrophoresis of the affinity-purified receptor revealed overlapping spots of 69 kDa and of pI 6.8-7.1 pointing to a microheterogeneity of the carbohydrate moiety. Elucidation of the key structural features of the B2 receptor protein will aid in understanding the structure-function relationships governing this prototypic peptide receptor.
人缓激肽B2受体属于G蛋白偶联受体家族。为了表征该受体蛋白,我们溶解了携带B2受体的培养人包皮成纤维细胞的细胞膜。在还原条件下,溶解的受体与标记的激动剂125I-Tyr0-缓激肽或标记的拮抗剂125I-(4-羟基-苯基-丙酰基)-HOE140进行亲和交联,在SDS-聚丙烯酰胺凝胶电泳中显示出表观分子量为69 kDa的主要条带,在非还原条件下为59 kDa。每种未标记配体1000倍的摩尔过量淬灭了特异性标记,表明激动剂和拮抗剂竞争重叠的结合位点。受体与缓激肽或HOE140的共价偶联,随后用特异性抗配体抗体进行蛋白质印迹和免疫印迹,证实受体的主要配体结合形式为69 kDa。带有缓激肽内部镜像的抗独特型抗体(哈斯曼,M.,布施科,J.,福斯纳,A.,罗舍尔,A.A.,霍贝克,J.,伯奇,R.M.,和米勒-埃斯特尔,W.(1991年)《免疫学杂志》147,3882 - 3892)免疫沉淀125I标记的受体,得到一条68 kDa的主要条带和一条47 kDa的次要条带,表明存在部分蛋白水解。125I标记受体的化学去糖基化使表观分子量从69 kDa变为44 kDa,表明该受体高度糖基化。亲和纯化受体的二维电泳显示出69 kDa且pI为6.8 - 7.1的重叠斑点,表明碳水化合物部分存在微异质性。阐明B2受体蛋白的关键结构特征将有助于理解控制这种原型肽受体的结构 - 功能关系。